These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36621823)

  • 1. Do Regions of Increased Inflammation Progress to New White Matter Hyperintensities?: A Longitudinal Positron Emission Tomography-Magnetic Resonance Imaging Study.
    Tozer DJ; Brown RB; Walsh J; Hong YT; Williams GB; O'Brien JT; Aigbirhio FI; Fryer TD; Markus HS
    Stroke; 2023 Feb; 54(2):549-557. PubMed ID: 36621823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Abnormalities in White Matter Pathways as Interface to Small Vessels Disease and Cognition in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Individuals.
    Jacobs HIL; Schoemaker D; Torrico-Teave H; Zuluaga Y; Velilla-Jimenez L; Ospina-Villegas C; Lopera F; Arboleda-Velasquez JF; Quiroz YT
    Brain Connect; 2022 Feb; 12(1):52-60. PubMed ID: 33980027
    [No Abstract]   [Full Text] [Related]  

  • 3. Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI.
    De Guio F; Vignaud A; Chabriat H; Jouvent E
    J Cereb Blood Flow Metab; 2018 Sep; 38(9):1654-1663. PubMed ID: 28128022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity.
    van Leijsen EMC; Bergkamp MI; van Uden IWM; Ghafoorian M; van der Holst HM; Norris DG; Platel B; Tuladhar AM; de Leeuw FE
    Stroke; 2018 Jun; 49(6):1386-1393. PubMed ID: 29724890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Yao M; Jouvent E; During M; Godin O; Hervé D; Guichard JP; Zhu YC; Gschwendtner A; Opherk C; Dichgans M; Chabriat H
    Stroke; 2012 Dec; 43(12):3252-7. PubMed ID: 23185048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hypertension and neurovascular inflammation in both normal-appearing white matter and white matter hyperintensities.
    Solé-Guardia G; Custers E; de Lange A; Clijncke E; Geenen B; Gutierrez J; Küsters B; Claassen JAHR; de Leeuw FE; Wiesmann M; Kiliaan AJ
    Acta Neuropathol Commun; 2023 Jan; 11(1):2. PubMed ID: 36600303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Walsh J; Tozer DJ; Sari H; Hong YT; Drazyk A; Williams G; Shah NJ; O'Brien JT; Aigbirhio FI; Rosenberg G; Fryer TD; Markus HS
    Brain; 2021 Jun; 144(5):1361-1371. PubMed ID: 34000009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presumed periventricular venous infarction on magnetic resonance imaging and its association with increased white matter edema in CADASIL.
    Yu X; Yin X; Hong H; Wang S; Jiaerken Y; Xu D; Zhang F; Zhang R; Yang L; Zhang B; Zhang M; Huang P
    Eur Radiol; 2023 Nov; 33(11):8057-8066. PubMed ID: 37284868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging Tissue Signatures Associated With White Matter Changes Due to Sporadic Cerebral Small Vessel Disease Indicate That White Matter Hyperintensities Can Regress.
    Jochems ACC; Muñoz Maniega S; Clancy U; Arteaga C; Jaime Garcia D; Chappell FM; Hewins W; Locherty R; Backhouse EV; Barclay G; Jardine C; McIntyre D; Gerrish I; Kampaite A; Sakka E; Valdés Hernández M; Wiseman S; Bastin ME; Stringer MS; Thrippleton MJ; Doubal FN; Wardlaw JM
    J Am Heart Assoc; 2024 Feb; 13(3):e032259. PubMed ID: 38293936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL.
    Opherk C; Gonik M; Duering M; Malik R; Jouvent E; Hervé D; Adib-Samii P; Bevan S; Pianese L; Silvestri S; Dotti MT; De Stefano N; Liem M; Boon EM; Pescini F; Pachai C; Bracoud L; Müller-Myhsok B; Meitinger T; Rost N; Pantoni L; Lesnik Oberstein S; Federico A; Ragno M; Markus HS; Tournier-Lasserve E; Rosand J; Chabriat H; Dichgans M
    Stroke; 2014 Apr; 45(4):968-72. PubMed ID: 24578207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.
    Patel B; Markus HS
    Int J Stroke; 2011 Feb; 6(1):47-59. PubMed ID: 21205241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch of MRI White Matter Hyperintensities and Gait Function in Patients With Cerebral Small Vessel Disease.
    Wu L; Wang Z; Zhou X; Kong Q; Zhang Y; Xu S; Huang H; Luo X
    J Magn Reson Imaging; 2024 Aug; 60(2):550-558. PubMed ID: 37921545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral White Matter and Slow Gait: Contribution of Hyperintensities and Normal-appearing Parenchyma.
    Rosario BL; Rosso AL; Aizenstein HJ; Harris T; Newman AB; Satterfield S; Studenski SA; Yaffe K; Rosano C;
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):968-73. PubMed ID: 26755683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
    Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease.
    Muñoz Maniega S; Chappell FM; Valdés Hernández MC; Armitage PA; Makin SD; Heye AK; Thrippleton MJ; Sakka E; Shuler K; Dennis MS; Wardlaw JM
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):644-656. PubMed ID: 26933133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion.
    Dichgans M; Pütz B; Boos D; Auer DP
    AJNR Am J Neuroradiol; 2003; 24(6):1083-9. PubMed ID: 12812930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of venous integrity in cerebral small vessel disease: a 7-T MRI study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
    De Guio F; Vignaud A; Ropele S; Duering M; Duchesnay E; Chabriat H; Jouvent E
    Stroke; 2014 Jul; 45(7):2124-6. PubMed ID: 24867926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging revealed different pathological processes of white matter hyperintensities.
    Min ZG; Shan HR; Xu L; Yuan DH; Sheng XX; Xie WC; Zhang M; Niu C; Shakir TM; Cao ZH
    BMC Neurol; 2021 Mar; 21(1):128. PubMed ID: 33740898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease.
    Rudilosso S; Chui E; Stringer MS; Thrippleton M; Chappell F; Blair GW; Garcia DJ; Doubal F; Hamilton I; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; van Oostenbrugge R; Duering M; Dichgans M; Wardlaw JM;
    Neurology; 2022 Aug; 99(5):e440-e452. PubMed ID: 35606147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.